Latest Biotech Startup Funding Rounds
Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.
- Funding disclosed in full
- $103M
- Median round
- $51.5M
- Rounds in calculation
- 2
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Biotia Clinical metagenomic tests and pathogen genomics software that help clinicians investigate challenging infections and detect antimicrobial resistance markers. | $9MUndisclosed | HealthtechUnited States | |||
| TriGemX Bio A clinical-stage biotechnology company developing elismetrep, an investigational oral medicine that blocks TRPM8 channels for the acute treatment of migraine. | $94MUndisclosed | BiotechnologyUnited States | TCGXLeadThe Column GroupLeadViking Global InvestorsLead |
Active investors
Explore investors- TCGX1 round · 1 led
- The Column Group1 round · 1 led
- Viking Global Investors1 round · 1 led
- Clive Fields1 round · 0 led
- Cloquet Capital Partners1 round · 0 led
- Continuum Health Ventures1 round · 0 led